Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report

After more than a year of Coronavirus disease 2019 pandemic, in 2021 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination have been made possible and vaccine was distributed globally. Since then, there have been reports of symptoms following SARS-CoV-2 vaccination, including neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunawan, Pricilla Yani, Tiffani, Pamela, Lalisang, Lilie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606431/
https://www.ncbi.nlm.nih.gov/pubmed/36263653
http://dx.doi.org/10.9758/cpn.2022.20.4.777
_version_ 1784818297399672832
author Gunawan, Pricilla Yani
Tiffani, Pamela
Lalisang, Lilie
author_facet Gunawan, Pricilla Yani
Tiffani, Pamela
Lalisang, Lilie
author_sort Gunawan, Pricilla Yani
collection PubMed
description After more than a year of Coronavirus disease 2019 pandemic, in 2021 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination have been made possible and vaccine was distributed globally. Since then, there have been reports of symptoms following SARS-CoV-2 vaccination, including neurological symptoms of ascending paralysis known as Guillain-Barre syndrome. In this report, we describe the first case of Guillain-Barre syndrome following vaccination in Indonesia. Symptoms of ascending paralysis were of late onset after the first dose, however, were full blown after receiving the second dose followed by left-sided facial paralysis.
format Online
Article
Text
id pubmed-9606431
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean College of Neuropsychopharmacology
record_format MEDLINE/PubMed
spelling pubmed-96064312022-11-30 Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report Gunawan, Pricilla Yani Tiffani, Pamela Lalisang, Lilie Clin Psychopharmacol Neurosci Case Report After more than a year of Coronavirus disease 2019 pandemic, in 2021 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination have been made possible and vaccine was distributed globally. Since then, there have been reports of symptoms following SARS-CoV-2 vaccination, including neurological symptoms of ascending paralysis known as Guillain-Barre syndrome. In this report, we describe the first case of Guillain-Barre syndrome following vaccination in Indonesia. Symptoms of ascending paralysis were of late onset after the first dose, however, were full blown after receiving the second dose followed by left-sided facial paralysis. Korean College of Neuropsychopharmacology 2022-11-30 2022-11-30 /pmc/articles/PMC9606431/ /pubmed/36263653 http://dx.doi.org/10.9758/cpn.2022.20.4.777 Text en Copyright© 2022, Korean College of Neuropsychopharmacology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Gunawan, Pricilla Yani
Tiffani, Pamela
Lalisang, Lilie
Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report
title Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report
title_full Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report
title_fullStr Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report
title_full_unstemmed Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report
title_short Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report
title_sort guillain-barre syndrome following sars-cov-2 vaccination: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606431/
https://www.ncbi.nlm.nih.gov/pubmed/36263653
http://dx.doi.org/10.9758/cpn.2022.20.4.777
work_keys_str_mv AT gunawanpricillayani guillainbarresyndromefollowingsarscov2vaccinationacasereport
AT tiffanipamela guillainbarresyndromefollowingsarscov2vaccinationacasereport
AT lalisanglilie guillainbarresyndromefollowingsarscov2vaccinationacasereport

Ejemplares similares